Prempro news | Breaking Prempro news | Prempro

Possible heart benefit in hormome therapy-study

...Such women already may have been suffering the health effects of aging when they started HRT.NO INCREASED RISK OF HEART DISEASE Continued ...

© Reuters 2006.

All Rights Reserved.

1 Careers Reuters journalists are subject to the Reuters Editorial Handbook which requires fair presentation and disclosure of relevant interests.

...

New Data from Women's Health Initiative Study Show No Increased ...

... New Data from Women's Health Initiative Study Show No Increased Risk of Coronary Heart Disease with Conjugated Estrogens Alone In Any Age Group Studied lundi 13 février 23:00 Accès client / membre Recherche rapide Actualités Cotations Action Oblig.

Indice Warrant Fonds SCPI FCPI Devise -- Tous France Etats-unis Allemagne Italie Gde-Bretagne Suisse Canada Belgique Pays-Bas Espagne Portugal -- Devises Taux Index Exchange Préférences Contactez-nous WYETH Liste Portef.

virtuel US9830241009 - 983024100 Accès rapide : Cotations Passage d'ordre Intraday 5 jours Graphique Intraday Graphique Historique Actualités Communiqués Conseils Reco.

des analystes Avis des membres Bénéfice / Dividendes A propos de la société Données financières Forum Cours Graphique Actualités Conseils Consensus Société Forum Informations société Communiqués société Agenda Imprimer cet article Envoyer cet article à un ami PRNewswire le 13/02/2006 22h00 New Data from Women's Health Initiative Study Show No Increased Risk of Coronary Heart Disease with Conjugated Estrogens Alone In Any Age Group Studied MADISON, N.J., Feb.

13 /PRNewswire-FirstCall/ - Wyeth Pharmaceuticals, a division of Wyeth , reports that data published today in the Archives of Internal Medicine showed that in the estrogen-alone arm of the Women's Health Initiative (WHI) study, conjugated estrogens 0.625 mg therapy did not increase the risk...

Federal Judge Sets Trial Dates for Two Hormone Replacement Therapy ...

...Both are manufactured by Wyeth Pharmaceuticals.

There are approximately 6 million women taking In 2003, the two drugs had combined sales of $2.1 billion.

Although Premarin, the first HRT drug, was introduced in 1942 for the purpose of alleviating symptoms of menopause such as hot flashes and vaginal dryness, a study in the Journal of American Medical Association (“JAMAâ€) has linked it to ovarian cancer.

Women taking Those figures alone should prompt women to consult their physicians regarding alternative treatments or methods of treatment.

This is especially so for women who experience only minor symptoms of menopause such as vaginal dryness which respond to alternative treatments such as creams and vitamin E.

The most important thing stressed by researchers and medical professionals alike is that In addition, women who ar...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news

Health and Fitness